Obesity and Cancer: The Oil that Feeds the Flame.

[1]  Brian Goodman,et al.  The microbiome and cancer , 2018, The Journal of pathology.

[2]  K. Deisseroth,et al.  Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer , 2015, Cell.

[3]  Fredrik H. Karlsson,et al.  Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation , 2015, Cell metabolism.

[4]  S. Gygi,et al.  S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction , 2015, Science.

[5]  H. Deng,et al.  The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1 , 2015, Nature.

[6]  M. Fasshauer,et al.  Adipokines in health and disease. , 2015, Trends in pharmacological sciences.

[7]  K. Ross,et al.  Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism , 2015, Nature.

[8]  N. Sattar,et al.  Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis , 2015, PloS one.

[9]  I. Gukovsky,et al.  Impaired autophagy triggers chronic pancreatitis: lessons from pancreas-specific atg5 knockout mice. , 2015, Gastroenterology.

[10]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[11]  K. Hoehn,et al.  Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. , 2015, Journal of hepatology.

[12]  Omry Koren,et al.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome , 2015, Nature.

[13]  H. Moch,et al.  Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.

[14]  M. Karin,et al.  ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. , 2014, Cancer cell.

[15]  Harry J. Flint,et al.  The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.

[16]  Shawn W. Polson,et al.  High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity , 2014, Nature.

[17]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[18]  J. Gómez-Reino,et al.  An update on leptin as immunomodulator , 2014, Expert review of clinical immunology.

[19]  W. Ouyang,et al.  Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes , 2014, Nature.

[20]  J. Olefsky,et al.  Macrophages, immunity, and metabolic disease. , 2014, Immunity.

[21]  M. Karin,et al.  Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. , 2014, Cell metabolism.

[22]  Mason R. Mackey,et al.  TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. , 2014, The Journal of clinical investigation.

[23]  J. Dufour,et al.  Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. , 2014, Journal of hepatology.

[24]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[25]  R. Savan,et al.  The role of the IL-22/IL-22R1 axis in cancer. , 2014, Cytokine & growth factor reviews.

[26]  T. Hansen,et al.  Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond , 2014, Diabetologia.

[27]  Andmorgan R. Fisher,et al.  Altered profile of human gut microbiome is associated with cirrhosis and its complications. , 2014, Journal of hepatology.

[28]  Y. Abed,et al.  Epidemiology of obesity in developing countries: challenges and prevention , 2014 .

[29]  A. Chawla,et al.  Metabolic regulation of immune responses. , 2014, Annual review of immunology.

[30]  A. Cuervo,et al.  Liver autophagy: much more than just taking out the trash , 2014, Nature Reviews Gastroenterology &Hepatology.

[31]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[32]  M. Karin,et al.  IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. , 2014, Seminars in immunology.

[33]  Hui Shen,et al.  Meta-analysis of genome-wide association data identifies novel susceptibility loci for obesity. , 2014, Human molecular genetics.

[34]  Bruce M. Spiegelman,et al.  What We Talk About When We Talk About Fat , 2014, Cell.

[35]  M. Karin,et al.  Sestrins orchestrate cellular metabolism to attenuate aging. , 2013, Cell metabolism.

[36]  M. Serlie,et al.  Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. , 2013, Cell metabolism.

[37]  Kristen Jepsen,et al.  Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling , 2013, Cell.

[38]  Brendan J. Quinn,et al.  Repositioning metformin for cancer prevention and treatment , 2013, Trends in Endocrinology & Metabolism.

[39]  K. Jablonski,et al.  Salicylate (Salsalate) in Patients With Type 2 Diabetes , 2013, Annals of Internal Medicine.

[40]  Eliseo Guallar,et al.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2013, American journal of epidemiology.

[41]  Masahira Hattori,et al.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.

[42]  A. Moorman,et al.  Hepatitis C in the United States. , 2013, The New England journal of medicine.

[43]  T. Deerinck,et al.  Loss of acinar cell IKKα triggers spontaneous pancreatitis in mice. , 2013, The Journal of clinical investigation.

[44]  L. Palmer,et al.  Association between liver‐specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease , 2013, Hepatology.

[45]  K. Jensen,et al.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[46]  A. Saito,et al.  Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue , 2012, Scientific Reports.

[47]  C. Datz,et al.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.

[48]  I. Gukovsky,et al.  Autophagy and pancreatitis. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[49]  J. Mason,et al.  Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. , 2012, The Journal of nutritional biochemistry.

[50]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[51]  J. Bressan,et al.  Potential mechanisms for the emerging link between obesity and increased intestinal permeability. , 2012, Nutrition research.

[52]  S. Devkota,et al.  Lymphotoxin regulates commensal responses to enable diet-induced obesity , 2012, Nature Immunology.

[53]  Derek S. Chan,et al.  The Pancreas Cancer Microenvironment , 2012, Clinical Cancer Research.

[54]  Mary T. Brinkoetter,et al.  Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice , 2012, Gut.

[55]  K. Olive,et al.  Silencing the killers: paracrine immune suppression in pancreatic cancer. , 2012, Cancer Cell.

[56]  J. Moscat,et al.  p62: a versatile multitasker takes on cancer. , 2012, Trends in biochemical sciences.

[57]  G. Tarantino,et al.  Hepatic Steatosis and Disease Activity in Subjects with Psoriatic Arthritis Receiving Tumor Necrosis Factor-α Blockers , 2012, The Journal of Rheumatology.

[58]  H. El‐Serag,et al.  458 The Rising Incidence of Hepatocellular Carcinoma in the United States: an Update , 2012 .

[59]  C. Mantzoros,et al.  The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.

[60]  F. Bäckhed,et al.  Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice , 2012, Gut.

[61]  R. Bronson,et al.  Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice , 2012, Science Signaling.

[62]  G. Núñez,et al.  Sensing and reacting to microbes through the inflammasomes , 2012, Nature Immunology.

[63]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[64]  M. Karin,et al.  Obesity, autophagy and the pathogenesis of liver and pancreatic cancers , 2012, Journal of gastroenterology and hepatology.

[65]  Gary K. Chen,et al.  Meta-analysis identifies common variants associated with body mass index in East Asians , 2012, Nature Genetics.

[66]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[67]  Ruiying Zhao,et al.  KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[68]  Wen Tan,et al.  Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations , 2011, Nature Genetics.

[69]  D. Tuveson,et al.  Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. , 2011, The Journal of clinical investigation.

[70]  C. Mantzoros,et al.  Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. , 2011, Metabolism: clinical and experimental.

[71]  M. Hudgens,et al.  Obesity is associated with impaired immune response to influenza vaccination in humans , 2011, International Journal of Obesity.

[72]  M. Karin,et al.  Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation , 2011, Cell.

[73]  J. Pankow,et al.  Genome-Wide Detection of Allele Specific Copy Number Variation Associated with Insulin Resistance in African Americans from the HyperGEN Study , 2011, PloS one.

[74]  Xiangmei Zhou,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[75]  S. Schneeweiss,et al.  Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. , 2011, JAMA.

[76]  S. Sookoian,et al.  Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.

[77]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[78]  T. Sugimura,et al.  Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. , 2011, Gastroenterology.

[79]  R. Ahima,et al.  TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. , 2011, The Journal of clinical endocrinology and metabolism.

[80]  Keiji Tanaka,et al.  Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells , 2011, The Journal of cell biology.

[81]  Y. Eishi,et al.  Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.

[82]  K. Takeda,et al.  Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis , 2011, Gut.

[83]  Lee H. Dicker,et al.  Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity , 2011, Nature.

[84]  Udo Hoffmann,et al.  Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits , 2011, PLoS genetics.

[85]  Manal M. Hassan,et al.  Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[86]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[87]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[88]  A. Tamakoshi,et al.  An Overview of Genetic Polymorphisms and Pancreatic Cancer Risk in Molecular Epidemiologic Studies , 2010, Journal of epidemiology.

[89]  O. Cummings,et al.  Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. , 2010, Gastroenterology.

[90]  R. Watanabe,et al.  The Genetics of Insulin Resistance: Where’s Waldo? , 2010, Current diabetes reports.

[91]  Sarah Hummasti,et al.  Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes , 2010, Circulation research.

[92]  Ping Li,et al.  Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. , 2010, Cell metabolism.

[93]  B. S. Mohammed,et al.  Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women , 2010, Diabetes.

[94]  Rocio Lopez,et al.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.

[95]  M. McCarthy,et al.  Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes , 2010, BMC Medical Genetics.

[96]  E. White,et al.  Role of autophagy in suppression of inflammation and cancer. , 2010, Current opinion in cell biology.

[97]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[98]  M. Karin,et al.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.

[99]  H. Takeda,et al.  Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. , 2010, World journal of gastroenterology.

[100]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[101]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[102]  S. Klein,et al.  Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.

[103]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[104]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[105]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[106]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[107]  R. Schwabe,et al.  CCR1 and CCR5 promote hepatic fibrosis in mice. , 2009, The Journal of clinical investigation.

[108]  N. Schork,et al.  Heritability of nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[109]  Gongshe Yang,et al.  Interleukin-6 stimulates lipolysis in porcine adipocytes , 2008, Endocrine.

[110]  S. Akira,et al.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.

[111]  D. Klionsky,et al.  How to live long and prosper: autophagy, mitochondria, and aging. , 2008, Physiology.

[112]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[113]  Subhajyoti De,et al.  Common variants near MC4R are associated with fat mass, weight and risk of obesity , 2008, Nature Genetics.

[114]  Martin Wiseman,et al.  The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective , 2008, Proceedings of the Nutrition Society.

[115]  J. Bastard,et al.  Adipokines: the missing link between insulin resistance and obesity. , 2008, Diabetes & metabolism.

[116]  Masaaki Komatsu,et al.  Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.

[117]  M. Karin,et al.  JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.

[118]  H. Ellingsgaard,et al.  Increased Number of Islet-Associated Macrophages in Type 2 Diabetes , 2007, Diabetes.

[119]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .

[120]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[121]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[122]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[123]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[124]  Qihua Sun,et al.  Autophagy Gene-Dependent Clearance of Apoptotic Cells during Embryonic Development , 2007, Cell.

[125]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[126]  M. Dewhirst,et al.  Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. , 2006, Cancer research.

[127]  L. Macia,et al.  Impairment of Dendritic Cell Functionality and Steady-State Number in Obese Mice1 , 2006, The Journal of Immunology.

[128]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[129]  M. Karin,et al.  Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates , 2006, Proceedings of the National Academy of Sciences.

[130]  K. Yagui,et al.  Subcutaneous Fat Modulates Insulin Sensitivity in Mice by Regulating TNF-α Expression in Visceral Fat , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[131]  A. Colell,et al.  Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. , 2006, Cell metabolism.

[132]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[133]  Kevin M. Ryan,et al.  DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis , 2006, Cell.

[134]  T. Reinehr,et al.  High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. , 2005, Metabolism: clinical and experimental.

[135]  R. Mooney,et al.  Interleukin-6 depletion selectively improves hepatic insulin action in obesity. , 2005, Endocrinology.

[136]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[137]  Masaaki Komatsu,et al.  Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice , 2005, The Journal of cell biology.

[138]  Dario R Alessi,et al.  Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.

[139]  L. Poellinger,et al.  Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. , 2004, Diabetes.

[140]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[141]  T. Reinehr,et al.  Adiponectin before and after weight loss in obese children. , 2004, The Journal of clinical endocrinology and metabolism.

[142]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[143]  Donald D Hensrud,et al.  Splanchnic lipolysis in human obesity. , 2004, The Journal of clinical investigation.

[144]  A. Poullis,et al.  Bowel Inflammation as Measured by Fecal Calprotectin , 2004, Cancer Epidemiology Biomarkers & Prevention.

[145]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[146]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[147]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[148]  Jaakko Tuomilehto,et al.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.

[149]  K. McGlynn,et al.  The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.

[150]  J. Tuomilehto,et al.  Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. , 2003, Diabetes.

[151]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[152]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[153]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[154]  A. Siddiqui,et al.  Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. , 2002, Biochemical pharmacology.

[155]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[156]  V. Manganiello,et al.  Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. , 2002, Diabetes.

[157]  A. Martí,et al.  Obesity and immunocompetence , 2002, European Journal of Clinical Nutrition.

[158]  A. Rocchini,et al.  Childhood obesity and a diabetes epidemic. , 2002, The New England journal of medicine.

[159]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[160]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[161]  M. Borkenstein,et al.  Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program , 2001, International Journal of Obesity.

[162]  T. Yamakawa,et al.  T lymphopenia in genetically obese-diabetic Wistar fatty rats: effects of body weight reduction on T cells. , 2000, Metabolism: clinical and experimental.

[163]  J. Flier,et al.  Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. , 2000, The Journal of clinical investigation.

[164]  R. Hruban,et al.  Genetic progression in the pancreatic ducts. , 2000, The American journal of pathology.

[165]  T. Valle,et al.  The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.

[166]  B. Sipos,et al.  Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution , 1999, Virchows Archiv.

[167]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[168]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[169]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[170]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[171]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[172]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[173]  Michael N. Edmonson,et al.  Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma. , 2014, Cancer genomics & proteomics.

[174]  H. Rajkumar,et al.  The Impact of Obesity on Immune Response to Infection and Vaccine: An Insight into Plausible Mechanisms , 2013 .

[175]  E. Diamandis,et al.  Pancreatic cancer. , 2013, Clinical chemistry.

[176]  K. Al-Kuraya,et al.  Role of leptin and its receptors in the pathogenesis of thyroid cancer. , 2011, International journal of clinical and experimental pathology.

[177]  L. N. Valenti,et al.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[178]  Hirokazu Takahashi,et al.  Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. , 2009, International journal of oncology.

[179]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.

[180]  Wan-Wan Lin,et al.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis , 2009, Nature.

[181]  N. Katunuma,et al.  Impaired autophagic flux mediates acinar cell vacuole formation and trypsinogen activation in rodent models of acute pancreatitis. , 2009, The Journal of clinical investigation.

[182]  C. Knauf,et al.  Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes , 2007 .

[183]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[184]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[185]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[186]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[187]  Kurt Zatloukal,et al.  p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. , 2002, The American journal of pathology.

[188]  U. Visco-Comandini,et al.  Metformin in non-alcoholic steatohepatitis , 2002, The Lancet.

[189]  J. Kolls,et al.  An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. , 1998, Endocrinology.

[190]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[191]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.